Skip to content
Home
About CROSSJECT
About CROSSJECT
Governance
OUR VALUES
ZENEO® technology
A unique technology platform
Technology for human factors
Clinical effectiveness
PIPELINE
Investors
Company presentation
analyst coverage
Press release
Our news
PROFILE AND FINANCIAL CALENDAR
Newsletter
Career
Contact
X
Home
About us
About CROSSJECT
Governance
Our values
ZENEO® technology
A unique technology platform
Technology for human factors
Clinical effectiveness
PIPELINE
Investors
Company presentation
Press release
Profile and financial calendar
Analyst coverage
Our news
Newsletter
Career
Contact
Français
English
X
Completion of the transactions announced in December 2024 relating to the amendment of the convertible bonds subscribed by an entity affiliated to Heights Capital Management, inc. (“Heights”) and the issue of a second assimilable tranche
February 6, 2025
20250206 Crossject New Tranche EN